Skip to Main content Skip to Navigation
Journal articles

Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans

Abstract : There are few studies in humans dealing with the relationship between physico-chemical properties of drugs and their systemic bioavailability after administration via oral inhalation route (Fpulm). Getting further insight in the determinants of Fpulm after oral pulmonary inhalation could be of value for drugs considered for a systemic delivery as a result of poor oral bioavailability, as well as for drugs considered for a local delivery to anticipate their undesirable systemic effects. To better delineate the parameters influencing the systemic delivery after oral pulmonary inhalation in humans, we studied the influence of physico-chemical and permeability properties obtained in silico on the rate and extent of Fpulm in a series of 77 compounds with or without marketing approval for pulmonary delivery, and intended either for local or for systemic delivery. Principal component analysis (PCA) showed mainly that Fpulm was positively correlated with Papp and negatively correlated with %TPSA, without a significant influence of solubility and ionization fraction, and no apparent link with lipophilicity and drug size parameters. As a result of the small sample set, the performance of the different models as predictive of Fpulm were quite average with random forest algorithm displaying the best performance. As a whole, the different models captured between 50 to 60% of the variability with a prediction error of less than 20%. Tmax data suggested a significant positive influence of lipophilicity on absorption rate while charge apparently had no influence. A significant linear relationship between Cmax and dose (R(2) = "0.79) highlighted that Cmax was primarily dependent on dose and absorption rate and could be used to estimate Cmax in humans for new inhaled drugs.
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03222648
Contributor : Laurent Jonchère <>
Submitted on : Wednesday, June 16, 2021 - 10:36:31 AM
Last modification on : Monday, June 21, 2021 - 4:05:11 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2021-10-23

Please log in to resquest access to the document

Identifiers

Citation

Astrid Bacle, Guillaume Bouzillé, Arnaud Bruyère, Marc Cuggia, Olivier Fardel, et al.. Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans. European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2021, ⟨10.1016/j.ejpb.2021.04.014⟩. ⟨hal-03222648⟩

Share

Metrics

Record views

42